Author

Weixin Wang

National Institutes of HealthORCID 0000-0001-7693-3374Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Weixin Wang1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Amanda DayiD· 1 shared Anish ThomasiD· 1 shared Azam GhafooriD· 1 shared Devon AtkinsoniD· 1 shared Haoxuan YingiD· 1 shared Kanak ParmariD· 1 shared Katherine R. CalvoiD· 1 shared Laura BasseliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amanda DayORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc- Driven Small Cell Lung Cancer

Azam Ghafoor, Linying Zhu, Zoë Weaver Ohler, Rajaâ El Meskini, Haoxuan Ying, Devon Atkinson, Amanda Day, Nathan Pate, Laura Bassel, Weixin Wang, Katherine R. Calvo, Lőrinc Sándor Pongor, Kanak Parmar, Yves G. Pommier, Anish Thomas, Yilun Sun

This study shows that HDAC inhibition with entinostat enhances immunotherapy response in SCLC by reprogramming tumor immunology and neuroendocrine status.

Molecular Cancer Therapeutics · Apr 30, 2026Peer-reviewedCancer Biology